A physician at Optimum Oncology Hematology Associates in Pembroke Pines, Florida, Matthew Taub offers customized care for people suffering from a variety of conditions, including both benign and malignant disorders. Drawing on 20 years of experience as a physician, Matthew Taub designs evidence-based treatment plans. Over the last decade, biomarkers have played an increasingly important role in helping physicians to make important decisions related to cancer treatment.
A biomarker is a biological molecule found in a person’s blood, body fluids, or tissues that is a sign of a normal or abnormal process in a condition or disease. Biomarkers are not limited to cancer and provide valuable information about the type of condition a patient has. When related to cancer, they can help physicians predict how a person’s specific type of cancer might behave.
With advanced pathology, biopsies or fluid samples provide information regarding biomarkers backed by published research that identifies and predicts how cancer cells respond to various treatments. Important decisions about combinations of treatments are all affected by the identified biomarkers. In addition, medical teams can use biomarkers to track how a patient’s cancer is responding to the treatment regimen.
With the data provided by biomarkers, physicians can also present a more accurate prognosis gleaned from data that tracks cancerous cells and their potential to change or return. As researchers continue to study, document, and publish reports related to various biomarkers, physicians are better equipped to customize a patients’ care, offering them the best possible plan to treat their specific type of cancer.
A biomarker is a biological molecule found in a person’s blood, body fluids, or tissues that is a sign of a normal or abnormal process in a condition or disease. Biomarkers are not limited to cancer and provide valuable information about the type of condition a patient has. When related to cancer, they can help physicians predict how a person’s specific type of cancer might behave.
With advanced pathology, biopsies or fluid samples provide information regarding biomarkers backed by published research that identifies and predicts how cancer cells respond to various treatments. Important decisions about combinations of treatments are all affected by the identified biomarkers. In addition, medical teams can use biomarkers to track how a patient’s cancer is responding to the treatment regimen.
With the data provided by biomarkers, physicians can also present a more accurate prognosis gleaned from data that tracks cancerous cells and their potential to change or return. As researchers continue to study, document, and publish reports related to various biomarkers, physicians are better equipped to customize a patients’ care, offering them the best possible plan to treat their specific type of cancer.
